Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What's new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis.

Therapeutic advances in cardiovascular disease - 1 Jan 2000

Zaidel Ezequiel J, Song Sol C, Sterba Juan J, Piccinato Agustina, Ramos María Candelaria, Cacia Silvina L

Abstract excerpt

Awareness, proper diagnosis and treatment of cardiac amyloidosis have increased, but there are still several unmet needs that have to be addressed for the optimal care of the disease. In this comprehensive review, we describe current and future treatments for both hereditary and wild-type TTR cardiac amyloidosis and also review lifestyle, including current challenges and opportunities for specific dietary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid Neuropathies, Familial
Share to Cardiomyopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cardiovascular Agents

Share to Exercise

Share to Exercise Therapy

Share to Prealbumin

Share to Risk Reduction Behavior

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 39530293
DOI: 10.1177/17539447241295957
PMCID: PMC11558729

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What's new in cardiac amyloidosis? Pharmacological treatment, physical activity, and care of patients with transthyretin cardiac amyloidosis.PMID 39530293Read ↗

Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.Semantic proximity Read ↗

[Recommendations update for the diagnosis and treatment of transthyretin variant amyloidosis (ATTRv)].Semantic proximity Read ↗

Pathophysiology and treatment of cardiac amyloidosis.Semantic proximity Read ↗

Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Semantic proximity Read ↗

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.Semantic proximity Read ↗

Transthyretin cardiac amyloidoses in older North Americans.Semantic proximity Read ↗

Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathySemantic proximity Read ↗

Transthyretin Cardiac Amyloidosis in Black Americans.Semantic proximity Read ↗

Current and Emerging Therapies for Hereditary Transthyretin Amyloidosis: Strides Towards a Brighter FutureSemantic proximity Read ↗

Guideline of transthyretin-related hereditary amyloidosis for cliniciansSemantic proximity Read ↗

Transthyretin Amyloid Cardiomyopathy–2025 Update: Current Diagnostic Approaches and Emerging Therapeutic OptionsSemantic proximity Read ↗

Cardiac Care of Patients with Cardiac Amyloidosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.